The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into The Possible Breaches Of Fiduciary Duty By The Board Of Clarient, Inc. In Connection With The Sale Of The Company To GE Healthcare – CLRT
Levi & Korsinsky is investigating the Board of Directors of Clarient, Inc. (“Clarient” or the “Company”) (NasdaqCM: CLRT) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to GE Healthcare, a unit of General Electric Company (NYSE: GE). Under the terms of the transaction, Clarient shareholders will receive $5.00 in cash for each Clarient common share and $20.00 in cash for each preferred share. The transaction values Clarient at approximately $580 million, net of cash and investments as of June 30, 2010. The Board of Directors of Clarient has approved the transaction and unanimously recommended that Clarient stockholders tender their shares in the transaction.
Click here to learn how to join the action: http://www.zlk.com/clarient-clrt.html, or call: 877-363-5972.
The investigation concerns whether the Clarient Board of Directors breached their fiduciary duties to Clarient stockholders by failing to adequately shop the Company before entering into this transaction and whether GE Healthcare is underpaying for Clarient shares, thus unlawfully harming Clarient stockholders. In particular, at least one analyst set a price target for Clarient common stock at $6.00 per share.
If you own common stock in Clarient and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/clarient-clrt.html.Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV